INDIANAPOLIS - As the prevalence of diabetes increases, Eli Lilly and Company is making strides to improve the availability of care to patients.
Lilly is increasing its insulin manufacturing capacity and adding two new insulin-cartridge-filling lines to the Indianapolis facility. Those cartridges can be used in insulin pens, which are growing in popularity.
Operations manager for filling, Lyle Fait, said the filling lines will pump 600 cartridge units a minute.
"With diabetes worldwide becoming almost epidemic in terms of the magnitude, this is the supply and demand that we are trying to meet in terms of keeping the global market supplied," Fait said.
Lilly is a global leader in the treatment of diabetes. The company introduced insulin as a treatment in 1923.
Officials said $400 million was being poured into the facilities, which will further Lilly’s pursuit of offering a full range of innovative options to diabetics.
National diabetes statistics show nearly 25.8 million people in the United States have diabetes. As many of seven million of those people are undiagnosed.
Ebola survivor: 'Very grateful to just be alive'
Nancy Writebol survived the Ebola virus. Now she wants to be a calm reminder of what the world needs to know.
Goodwill hosts 'Thrill of the Hunt' contest
If you like to do your Halloween partying on a budget, Goodwill has a contest tailored to you.
ISU data: Low rates of campus violence
Indiana State University police are working to assure the public that the campus is safe after two recent incidents, including a shooting…
Woman's family hopes for best amid deaths
Relatives of a Gary woman missing since February are awaiting word on whether she is one of Darren Vann's victims.
Indiana candidates in attack mode for final push
Indiana politicians are moving into attack mode as Election Day draws near.
Daylight Saving Time 101: Time to fall back
Here's a quick brushing-up on your daylight saving time details, besides the fact that it's coming up soon.